SCHEMBL9917196

SCHEMBL9917196

C=C[P+]([O-])(c1ccccc1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
TSHR P16473 1/20 0.38
HIF1A Q16665 1/20 0.36
KDM4E B2RXH2 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPT P10636 1/20 0.33
ALOX15 P16050 1/20 0.33
AKT1 P31749 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL35319498 0.72 ALDH1A1 (0.41) ALDH1A1TSHRHIF1AKDM4ECYP3A4
Bromide SCHEMBL20555667 0.70 TSHR (0.39) ALDH1A1TSHRHIF1AKDM4ECYP3A4
Hydrochloric Acid SCHEMBL28633975 0.70 ALDH1A1 (0.39) ALDH1A1TSHRHIF1AKDM4ECYP3A4
Bromide SCHEMBL2450382 0.70 ALDH1A1 (0.39) ALDH1A1TSHRHIF1AKDM4ECYP3A4
Fluoride Ion SCHEMBL9405342 0.70 ALDH1A1 (0.39) ALDH1A1TSHRHIF1AKDM4ECYP3A4
SCHEMBL3961571 0.69 CYP2C19 (0.38) ALDH1A1TSHRHIF1AKDM4EMAPT
Triphenylphosphine Oxide SCHEMBL7241281 0.67 HIF1A (0.45) ALDH1A1TSHRHIF1ACYP3A4
SCHEMBL31634029 0.65 ALDH1A1 (0.35) ALDH1A1TSHRHIF1AKDM4ECYP3A4
Bromide SCHEMBL16198007 0.64 TSHR (0.39) ALDH1A1TSHRHIF1AKDM4ECYP3A4
Bromide SCHEMBL22712399 0.64 ALDH1A1 (0.33) ALDH1A1TSHRHIF1AKDM4ECYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3794061-B1 PHOSPHORUS CONTAINING OLIGOMERS AND POLYMERS EMPA EIDGENOESSISCHE MAT & FORSCHUNGSANSTALT (CH) 2023-07-05 EP disclosed
US-11370736-B2 Synthesis of fluoro hemiacetals via transition metal-catalyzed fluoro ester and carboxamide hydrogenation TRIAD NATIONAL SECURITY, LLC (US) 2022-06-28 US disclosed
US-20210371591-A1 PHOSPHORUS CONTAINING OLIGOMERS AND POLYMERS EMPA EIDGENOESSISCHE MATERIALPRUEFUNGS- UND FORSCHUNGSANSTALT (CH) 2021-12-02 US disclosed
EP-3260441-B1 METHOD FOR PREPARING FORMAMIDE COMPOUND SHANGHAI GREENCARBON HI TECH CO LTD (CN) 2021-03-03 EP disclosed
US-20200308089-A1 SYNTHESIS OF FLUORO HEMIACETALS VIA TRANSITION METAL-CATALYZED FLUORO ESTER AND CARBOXAMIDE HYDROGENATION U.S. DEPARTMENT OF ENERGY 2020-10-01 US disclosed
US-10745367-B2 Method for preparing formamide compound Shanghai Greencarbon Hi-Tech Co., Ltd. (CN) 2020-08-18 US disclosed
US-10633403-B2 N-heterocyclic phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA (US) 2020-04-28 US disclosed
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis TRIAD NATIONAL SECURITY, LLC (US) 2020-02-04 US disclosed
EP-3569641-A1 PHOSPHORUS CONTAINING OLIGOMERS AND POLYMERS EMPA Eidgenössische Materialprüfungs- und Forschungsanstalt (CH) 2019-11-20 EP disclosed
US-10328089-B2 Fumagillol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2019-06-25 US disclosed
US-20110293897-A1 RELIEF PRINTING PLATE PRECURSOR FOR LASER ENGRAVING, PROCESS FOR MAKING RELIEF PRINTING PLATE, AND RELIEF PRINTING PLATE FUJIFILM CORPORATION (JP) 2011-12-01 US disclosed
US-20110198105-A1 NON-HALOGEN FLAME RETARDANT RESIN COMPOSITION AND ELECTRIC WIRE AND CABLE USING THE SAME HITACHI CABLE, LTD. (JP) 2011-08-18 US disclosed
US-20110198105-A1 NON-HALOGEN FLAME RETARDANT RESIN COMPOSITION AND ELECTRIC WIRE AND CABLE USING THE SAME HITACHI CABLE, LTD. (JP) 2011-08-18 US disclosed
US-20110159439-A1 THERMALLY CROSSLINKABLE RESIN COMPOSITION FOR LASER ENGRAVING, RELIEF PRINTING PLATE PRECURSOR FOR LASER ENGRAVING AND PROCESS FOR PRODUCING SAME, AND RELIEF PRINTING PLATE AND PROCESS FOR MAKING SAME FUJIFILM CORPORATION (JP) 2011-06-30 US disclosed
US-20110156317-A1 RESIN COMPOSITION FOR LASER ENGRAVING, RELIEF PRINTING STARTING PLATE FOR LASER ENGRAVING, PROCESS FOR MAKING RELIEF PRINTING PLATE, AND RELIEF PRINTING PLATE FUJIFILM CORPORATION (JP) 2011-06-30 US disclosed
US-20110156318-A1 RESIN COMPOSITION FOR LASER ENGRAVING, RELIEF PRINTING PLATE PRECURSOR FOR LASER ENGRAVING AND PROCESS FOR PRODUCING SAME, AND RELIEF PRINTING PLATE AND PROCESS FOR MAKING SAME FUJIFILM CORPORATION (JP) 2011-06-30 US disclosed
US-20110159438-A1 THERMALLY CROSSLINKABLE RESIN COMPOSITION FOR LASER ENGRAVING, RELIEF PRINTING STARTING PLATE FOR LASER ENGRAVING AND PROCESS FOR PRODUCING THE SAME, AND RELIEF PRINTING PLATE AND PROCESS FOR MAKING SAME FUJIFILM CORPORATION (JP) 2011-06-30 US disclosed
US-20110076613-A1 RESIN COMPOSITION FOR LASER ENGRAVING, RELIEF PRINTING PLATE PRECURSOR FOR LASER ENGRAVING AND METHOD FOR PRODUCING THE SAME, AND RELIEF PRINTING PLATE AND METHOD FOR MAKING THE SAME FUJIFILM CORPORATION (JP) 2011-03-31 US disclosed
US-7713449-B2 Polymer electrolytic material, polymer electrolytic part, membrane electrode assembly, and polymer electrolyte fuel cell TORAY INDUSTRIES, INC. (JP) 2010-05-11 US disclosed
US-7713449-B2 Polymer electrolytic material, polymer electrolytic part, membrane electrode assembly, and polymer electrolyte fuel cell TORAY INDUSTRIES, INC. (JP) 2010-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10550139-B2 Polydentate ligands and their complexes for molecular catalysis NANS, NCL, NCLN ALDH1A1 862/4885TSHR 4074/4885HIF1A 4392/4885
US-10745367-B2 Method for preparing formamide compound FH, CA3, CA2 ALDH1A1 2272/4885TSHR 3529/4885HIF1A 815/4885
US-10633403-B2 N-heterocyclic phosphines NANP, PPIP5K2, PHPT1 ALDH1A1 4621/4885TSHR 4125/4885HIF1A 3285/4885
US-20210371591-A1 PHOSPHORUS CONTAINING OLIGOMERS AND POLYMERS PHOSPHO1, PPIP5K2, PNKP ALDH1A1 4323/4885TSHR 4284/4885HIF1A 4864/4885
US-20200308089-A1 SYNTHESIS OF FLUORO HEMIACETALS VIA TRANSITION METAL-CATALYZED FLUORO ESTER AND CARBOXAMIDE HYDROGENATION FH, HIRA, HNF4A ALDH1A1 1005/4885TSHR 1790/4885HIF1A 1226/4885
US-10328089-B2 Fumagillol derivatives SULT2A1, METAP2, FAH ALDH1A1 315/4885TSHR 4255/4885HIF1A 2753/4885
US-11370736-B2 Synthesis of fluoro hemiacetals via transition metal-catalyzed fluoro ester and carboxamide hydrogenation FH, HIRA, HNF4A ALDH1A1 1005/4885TSHR 1790/4885HIF1A 1226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.